Abstract: The present invention relates to high intensity sweetener glycosides which have been modified using a glycosyltransferase so as to reduce off-flavours. The invention also relates to uses of the modified high intensity sweetener glycosides and methods of production thereof.

Abstract: The present invention relates to compositions comprising one or more probiotic bacterial strains and one or more lipid modifing active ingredients. The compositions can be used in the management of cholesterol and/or hypertension.

Abstract: The present invention relates to a composition comprising a levansucrase modified high intensity sweetener glycoside, a polysaccharide and an unmodified high intensity sweetener glycoside. The invention also relates to a method for enzymatically modifying a high intensity sweetener glycoside comprising contacting the high intensity sweetener glycoside with a levansucrase in the presence of a monosaccharide acceptor to produce an enzymatically modified high intensity sweetener glycoside and a polysaccharide. The invention also relates to the use of the composition as a low calorie sweet functional fibre, sweet prebiotic or as a bulk sugar replacement. The invention also relates to the use of a levansucrase for fructosylating a high intensity sweetener glycoside.

Abstract: The present invention relates to a non-digestible prebiotic oligosaccharide modified so as to incorporate one or more monosaccharide units thereon and have a higher sweetness value than the unmodified oligosaccharide. Uses and methods of producing the non-digestible prebiotic oligosaccharides are also described.

Abstract: The present invention relates to a non-digestible prebiotic oligosaccharide modified so as to incorporate one or more monosaccharide units thereon and have a higher sweetness value than the unmodified oligosaccharide. Uses and methods of producing the non-digestible prebiotic oligosaccharides are also described.

Abstract: The present invention relates to a composition comprising prebiotic, chromium and soluble fibre components, wherein the composition is formed by the agglomeration of the components into one or more granules. The invention also relates to methods of producing the one or more granules.

Abstract: The present invention relates to a Lactobacillus spp. selective prebiotic composition comprising one, or a mixture of two or more, of: xylooligosaccharides, cellobiose and/or gentiooligosaccharides. The present invention also relates to a synbiotic composition comprising a probiotic component comprising one or more strains of Lactobacillus rhamnosus and/or one or more strains of Lactobacillus plantarum and a prebiotic component comprising a growth medium which is specific for the growth of the probiotic component, wherein the prebiotic growth medium comprises one or more, or a mixture of two of more, components selected from: xylooligosaccharides, cellobiose and/or gentiooligosaccharides. The present invention also relates to methods of producing and selecting such compositions.

Abstract: The present invention relates to a prebiotic composition comprising a galacto oligosaccharide (GOS) produced from Lactobacillus plantarum, wherein the GOS acts as a selective growth medium for a chosen Lactobacillus plantarum probiotic bacterial strain, and wherein the GOS is substantially the same as the form produced by reverse ?-galactosidase reaction in the chosen probiotic bacterial strain. The present invention also relates to methods of producing GOS and related composition incorporating the GOS.

Abstract: The present invention relates to a non-digestible prebiotic oligosaccharide modified so as to incorporate one or more monosaccharide units thereon and have a higher sweetness value than the unmodified oligosaccharide. Uses and methods of producing the non-digestible prebiotic oligosaccharides are also described.

Abstract: The present invention relates to high intensity sweetener glycosides which have been modified using a glycosyltransferase so as to reduce off-flavours. The invention also relates to uses of the modified high intensity sweetener glycosides and methods of production thereof.

Abstract: The present invention relates to a prebiotic composition comprising: (i) a enzymatically modified high intensity sweetener glycoside; and an oligosaccharide. In particular, the invention relates to a galactosylated and/or fructosylated and/or deglycosylated high intensity sweetener glycoside; and (ii) an oligosaccharide obtained during the same enzymatic reaction. Uses and methods of producing the composition are also described.

Abstract: The present invention relates to a Lactobacillus spp. selective prebiotic composition comprising one, or a mixture of two or more, of: xylooligosaccharides, cellobiose and/or gentiooligosaccharides. The present invention also relates to a synbiotic composition comprising a probiotic component comprising one or more strains of Lactobacillus rhamnosus and/or one or more strains of Lactobacillus plantarum and a prebiotic component comprising a growth medium which is specific for the growth of the probiotic component, wherein the prebiotic growth medium comprises one or more, or a mixture of two of more, components selected from: xylooligosaccharides, cellobiose and/or gentiooligosaccharides. The present invention also relates to methods of producing and selecting such compositions.

Abstract: The present invention relates to compositions and foodstuffs for use in increasing gastrointestinal microbiota diversity comprising: a) glucomannan; b) chromium; and c) a prebiotic (FOS). The compositions and foodstuffs are particularly suited for that increasing gastrointestinal microbiota diversity over a prolonged period of time which can assist individuals in reducing their weight and, more importantly, maintaining their lower weight over the longer term.

Abstract: The present invention relates to compositions comprising one or more probiotic bacterial strains and one or more lipid modifying active ingredients. The compositions can be used in the management of cholesterol and/or hypertension.

Abstract: The present invention relates to a prebiotic composition comprising a galacto oligosaccharide (GOS) produced from Lactobacillus plantarum, wherein the GOS acts as a selective growth medium for a chosen Lactobacillus plantarum probiotic bacterial strain, and wherein the GOS is substantially the same as the form produced by reverse ?-galactosidase reaction in the chosen probiotic bacterial strain. The present invention also relates to methods of producing GOS and related composition incorporating the GOS.

Abstract: The present invention relates to a discovery platform for screening one or more Streptococcus, Lactobacillus or Propionibacterium bacterial strains for the ability to produce and/or produce a high yield of galactooligosaccharides (GOS) comprising assessing the ?-galactosidase activity of a strain under growth conditions and identifying whether the activity has: a) Miller Unit which are equal to or greater than about 60 for Streptococcus or Lactobacillus strains; or b) Miller Unit which are equal to or greater than about 3 for Propionibacterium strains. The present invention also relates to compositions incorporating GOS produced from bacterial strains identified by the screening process.

Abstract: The present invention relates to a prebiotic composition comprising a galacto oligosaccharide (GOS) produced from one or more Propionibacterium bacterial strains, wherein the GOS acts as a selective growth medium for Propionibacterium bacterial strains, and wherein the GOS is substantially the same as the form produced by reverse ?-galactosidase reaction for Propionibacterium bacterial strains. The present invention also relates to methods of producing GOS and related composition incorporating the GOS and is particularly useful in increasing propionate levels in colon of an individual so as to promote the growth of propionate secreting bacteria and regulate appetite.

Abstract: The present invention concerns nutritional compositions comprising oligosaccharides for controlling inflammatory bowel disease and related disorders, such as diarrhea and constipation.

Abstract: The present invention concerns nutritional compositions comprising oligosaccharides for controlling inflammatory bowel disease and related disorders, such as diarrhoea and constipation.

Abstract: The present invention concerns nutritional compositions comprising oligosaccharides for controlling inflammatory bowel disease and related disorders, such as diarrhea and constipation.